Cellectar Biosciences: Q2 Earnings Insights
Cellectar Biosciences (NASDAQ:CLRB) reported its Q2 earnings results on Friday, August 5, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday
Gainers
GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declining 8% on Friday.
Why Is Infrastructure and Energy Alternatives Higher By Around 29%? 37 Stocks Moving In Monday’s Mid-Day Session
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 104% to $1.3263 after the company announced that primary endpoint was met in study for its treatment of allergic rhinitis.
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers
Hanger (NYSE:HNGR) stock moved upwards by 27.1% to $18.75 during Thursday's after-market session. The company's market cap stands at $731.7 million.
Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday
Gainers
Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
Oppenheimer Assumes Cellectar Biosciences at Outperform, Announces Price Target of $5.5
Oppenheimer analyst Jeff Jones assumes Cellectar Biosciences (NASDAQ:CLRB) with a Outperform rating and announces Price Target of $5.5.